Comparison of women's breast cancer risk factors in Geneva, Switzerland and Shanghai, China.
暂无分享,去创建一个
G. Vlastos | A. Morabia | L. DeRoo | A. Vlastos | P. Mock
[1] D. Normile. Public health. A sense of crisis as China confronts ailments of affluence. , 2010, Science.
[2] P. Porter. Global trends in breast cancer incidence and mortality. , 2009, Salud publica de Mexico.
[3] Therese Hesketh,et al. Effects of reproductive and demographic changes on breast cancer incidence in China: a modeling analysis. , 2008, Journal of the National Cancer Institute.
[4] P. Porter,et al. "Westernizing" women's risks? Breast cancer in lower-income countries. , 2008, The New England journal of medicine.
[5] F. Bray,et al. The changing global patterns of female breast cancer incidence and mortality , 2004, Breast Cancer Research.
[6] J. Woo,et al. The epidemiology of cigarette smoking in Hong Kong Chinese women. , 2003, Preventive medicine.
[7] A. McTiernan. Behavioral risk factors in breast cancer: can risk be modified? , 2003, The oncologist.
[8] W. X. Zhu,et al. The One Child Family Policy , 2003, Archives of disease in childhood.
[9] Susan L. Morrow,et al. The acceptability of combined oral hormonal contraceptives in Shanghai, People's Republic of China. , 2003, Contraception.
[10] J. Cleland,et al. Contraceptive use before and after marriage in Shanghai. , 2003, Studies in family planning.
[11] Thomas E Rohan,et al. Cigarette smoking and the risk of breast cancer in women: a review of the literature. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[12] J. Ranstam,et al. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease , 2002, The Lancet.
[13] C. Kooperberg,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.
[14] L. Bernstein,et al. Rapidly rising breast cancer incidence rates among Asian‐American women , 2002, International journal of cancer.
[15] R. Goldbohm,et al. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease , 2001, The Lancet.
[16] Yawei Zhang,et al. Lactation Reduces Breast Cancer Risk in Shandong Province, China , 2001 .
[17] P. Goss,et al. Estrogen and the risk of breast cancer. , 2001, The New England journal of medicine.
[18] G. Colditz,et al. Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. , 2000, American journal of epidemiology.
[19] Jacques Ferlay,et al. Estimates of the worldwide incidence of 25 major cancers in 1990 , 1999, International journal of cancer.
[20] M. Costanza,et al. International variability in ages at menarche, first livebirth, and menopause. World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. , 1998, American journal of epidemiology.
[21] P. Oei,et al. Hormone Replacement Therapy in the Developing Countries , 1998, The Australian & New Zealand journal of obstetrics & gynaecology.
[22] Julian Peto,et al. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer , 1997, The Lancet.
[23] J. Bringer,et al. Obesity and breast cancer risk. , 1997, Human reproduction.
[24] Julian Peto,et al. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies , 1996, The Lancet.
[25] M. Bernstein,et al. Relation of breast cancer with passive and active exposure to tobacco smoke. , 1996, American journal of epidemiology.
[26] C. Haines,et al. The perception of the menopause and the climacteric among women in Hong Kong and southern China. , 1995, Preventive medicine.
[27] J. Russo,et al. Toward a physiological approach to breast cancer prevention. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[28] A M Nomura,et al. Migration patterns and breast cancer risk in Asian-American women. , 1993, Journal of the National Cancer Institute.
[29] M. J. Marshall,et al. Effect of radiotherapy upon enzymes of the glycolytic and related pathways in human uterine cancer. , 1979, British Journal of Cancer.
[30] C. Devine,et al. Obesity and Breast Cancer Risk Fact Sheet No. 56 , 2008 .
[31] M. Costanza,et al. Reproductive factors and incidence of breast cancer: An international ecological study , 2005, Sozial- und Präventivmedizin.
[32] L. Brinton,et al. Recent trends in breast cancer incidence and mortality , 2002, Environmental and molecular mutagenesis.
[33] K. McPherson,et al. ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. , 2000, BMJ.
[34] A. Rosén,et al. Nutritional, socioeconomic, and reproductive factors in relation to female breast cancer mortality: findings from a cross-national study. , 1996, Cancer detection and prevention.
[35] J L Kelsey,et al. Reproductive factors and breast cancer. , 1993, Epidemiologic reviews.
[36] Jacques Ferlay,et al. Cancer incidence in five continents. , 1976, IARC scientific publications.